In the context of esophageal, breast, and colorectal solid tumors, biomarkers such as PD-L1 score, tumor mutation burden (TMB), tumor-infiltrating lymphocytes (TILs), and microsatellite instability (MSI) have been considered closely linked to the effectiveness of NICT. This evidence concerns the gene CD274 and neoplasm.